Dell Seton Medical Center
Austin, Texas, 78701, United States
NCT Number: NCT04627077
The goal of this study will be to collect baseline patient reported outcome measures at the Livestrong Cancer Institutes (LCI) with the goal of improving quality care and to inform decision making by patients, providers, and researchers for future LCI initiatives.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Austin, Texas, 78701, United States
This proposed study is a descriptive study of the adult oncology population at the Seton Infusion Center in order to provide information about patient needs and identify areas for further research and resource allocation. The patient reported outcome measures being collected cover the following domains: anxiety, depression, fatigue, physical function, financial toxicity and pain. Patients and caregivers will be informed about the study and given the opportunity to enroll at the time of routine clinic visits at the Dell Seton Medical Center at The University of Texas Seton Infusion Center (SIC). Patients choosing to enroll in the study will be provided informed consent, and then allowed to complete the measures during their clinic visit on an iPad provided by the research staff. After IRB approval for a period of 1-2 months data collection will take place at the SIC clinic at DMS. Upon completion of the measures patients will be asked for an email address and phone number so that a follow up link to survey questions can be sent to them in 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Functional Assessment of Cancer Therapy (FACT-G)
Time frame: Baseline and 3 month follow up
PROMIS adaptive anxiety
Time frame: Baseline and 3 month follow up
PROMIS adaptive Depression
Time frame: Baseline and 3 month follow up
PROMIS adaptive pain
Time frame: Baseline and 3 month follow up
PROMIS adaptive physical function
Time frame: Baseline and 3 month follow up
PROMIS adaptive fatigue
Time frame: Baseline and 3 month follow up
Comprehensive Score for financial Toxicity (COST) questionnaire
Time frame: Baseline and 3 month follow up
The CAHPS® Cancer Care Survey
Time frame: Baseline and 3 month follow up
Brief Assessment Scale for Caregivers (BASC), range -27 to 12, higher scores poorer outcomes
University of Texas at Austin
Other
Acronym: LCI PROs
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07665697
Drug Therapy, Immune Checkpoint Inhibitors (ICIs)
Chengdu, China
View Trial DetailsNCT04996732
Drug Therapy, Neoplasms
Shanghai, China
View Trial DetailsNCT02423057
Neoplasms, Solid Tumors
Bethesda, Maryland, United States
View Trial DetailsNCT03872778
Neoplasms
Duarte, California, United States
View Trial Details